BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38085410)

  • 1. Characterization of gut microbiota in patients with stage 3-4 chronic kidney disease: a retrospective cohort study.
    Yang X; Cai S; Gong J; Zhang J; Lian M; Chen R; Zhou L; Bai P; Liu B; Zhuang M; Tan H; Xu J; Li M
    Int Urol Nephrol; 2024 May; 56(5):1751-1762. PubMed ID: 38085410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the gut microbiota in patients with chronic kidney disease.
    Hu X; Ouyang S; Xie Y; Gong Z; Du J
    Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
    [No Abstract]   [Full Text] [Related]  

  • 3. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
    Li F; Wang M; Wang J; Li R; Zhang Y
    Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects].
    Guirong YE; Minjie Z; Lixin YU; Junsheng YE; Lin Y; Lisha S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1401-1408. PubMed ID: 30613005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.
    Lu H; Gao NL; Tong F; Wang J; Li H; Zhang R; Ma H; Yang N; Zhang Y; Wang Y; Liang Z; Zeng H; Chen WH; Dong X
    Microbiol Spectr; 2021 Dec; 9(3):e0080221. PubMed ID: 34787462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic Toxin-Producing
    Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY
    Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uncovering specific taxonomic and functional alteration of gut microbiota in chronic kidney disease through 16S rRNA data.
    Zhang Y; Zhong W; Liu W; Wang X; Lin G; Lin J; Fang J; Mou X; Jiang S; Huang J; Zhao W; Zheng Z
    Front Cell Infect Microbiol; 2024; 14():1363276. PubMed ID: 38707511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis of Gut Microbiota in Patients with Chronic Kidney Disease.
    Yasuno T; Takahashi K; Tada K; Hiyamuta H; Watanabe M; Ito K; Arima H; Masutani K
    Intern Med; 2024 Feb; 63(3):347-352. PubMed ID: 37344438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.
    Yang CY; Chen TW; Lu WL; Liang SS; Huang HD; Tseng CP; Tarng DC
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review.
    Zhao J; Ning X; Liu B; Dong R; Bai M; Sun S
    Ren Fail; 2021 Dec; 43(1):102-112. PubMed ID: 33406960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
    Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
    Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium species diversity in gut microbiota of patients with renal failure.
    Khiabani SA; Haghighat S; Khosroshahi HT; Asgharzadeh M; Kafil HS
    Microb Pathog; 2022 Aug; 169():105667. PubMed ID: 35793779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota profile of patients on peritoneal dialysis: comparison with household contacts.
    Teixeira RR; de Andrade LS; Pereira NBF; Montenegro H; Hoffmann C; Cuppari L
    Eur J Clin Nutr; 2023 Jan; 77(1):90-97. PubMed ID: 35906334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity.
    Wang H; Ainiwaer A; Song Y; Qin L; Peng A; Bao H; Qin H
    Microbiome; 2023 Jan; 11(1):3. PubMed ID: 36624472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered gut microbiota and microbial biomarkers associated with chronic kidney disease.
    Lun H; Yang W; Zhao S; Jiang M; Xu M; Liu F; Wang Y
    Microbiologyopen; 2019 Apr; 8(4):e00678. PubMed ID: 30088332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal flora alterations in patients with early chronic kidney disease: a case-control study among the Han population in southwestern China.
    Hu Q; Wu K; Pan W; Zeng Y; Hu K; Chen D; Huang X; Zhang Q
    J Int Med Res; 2020 Jun; 48(6):300060520926033. PubMed ID: 32495708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific gut microbiome and metabolome changes in patients with continuous ambulatory peritoneal dialysis and comparison between patients with different dialysis vintages.
    Li J; Xing H; Lin W; Yu H; Yang B; Jiang C; Zhang J; Wu R; Ding F; Pei M; Yang H
    Front Med (Lausanne); 2023; 10():1302352. PubMed ID: 38249961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strongyloides stercoralis infection induces gut dysbiosis in chronic kidney disease patients.
    Hai NT; Hongsrichan N; Intuyod K; Pinlaor P; Yingklang M; Chaidee A; Pongking T; Anutrakulchai S; Cha'on U; Pinlaor S
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010302. PubMed ID: 36067216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD.
    Barba C; Soulage CO; Caggiano G; Glorieux G; Fouque D; Koppe L
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33255454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.